HIV Viral Suppression With Use of Long-Acting Antiretroviral Therapy in People With and Without Initial Viremia

This study uses electronic medical record data to compare 48-week viral load outcomes after starting long-acting antiretroviral therapy among people in the US with HIV with or without viremia from January 2021 through September 2024.